Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase

Molecular and Cellular Biology

Volumn 18, Issue 6, 1998, Pages 3509-3517

  Srivastava, Rakesh K ^a   Srivastava, Aparna R ^b   Korsmeyer, Stanley J ^c   Nesterova, Maria ^d   Cho Chung, Yoon S ^d   Longo, Dan L ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; CYSTEINE PROTEINASE; DOXORUBICIN; METHOTREXATE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; VINBLASTINE; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031813790     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.6.3509     Document Type: Article

References (48)

1. Blagosklonny, M. V., P. Giannakakou, W. S. El-Deiry, D. G. I. Kingston, P. I. Higgs, L. Neckers, and T. Fojo. 1997. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 57:130-135.
2. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
3. Boyd, J. M., G. J. Gallo, B. Elangovan, A. B. Houghton, S. Malstrom, B. J. Avery, R. G. Ebb, T. Subramanian, T. Chittenden, R. J. Lutz, and G. Chinnadurai. 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921-1928.
4. Carson, D. A., and J. M. Ribeiro. 1993. Apoptosis and disease. Lancet 341: 1251-1254.
5. Cheng, E. H., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690-694.
6. Cho-Chung, Y. S. 1990. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approach to therapy. Cancer Res. 50:7093-7100.
7. Cho-Chung, Y. S., M. Nesterova, A. Kondrashin, K. Noguchi, R. K. Srirastava, and S. Pepe. 1997. Antisense-protein kinase A: a single-gene-based therapeutic approach. Antisense Nucleic Acid Drug Dev. 7:217-223.
8. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ. 5:1041-1050.
9. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of ICE-like protease in Fas-mediated apoptosis. Nature 375:78-81.
10. Fernandes-Alnemri, T., G. Litwack, and E. S. Alnemri. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian-1β-converting enzyme. J. Biol. Chem. 269: 30761-30764.
11. Haldar, S., A. Basu, and C. M. Croce. 1997. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57:229-233.
12. Haldar, S., J. Chintapalli, and C. M. Croce. 1996. Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56:1253-1255.
13. Haldar, S., N. Jena, and C. M. Croce. 1995. Inactivation of bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92:4507-4511.
14. Harrison, D. J. 1995. Molecular mechanism of drug resistance in tumors. J. Pathol. 175:7-12.
15. Hickman, J. A. 1992. Apoptosis induced by anti-cancer drugs. Cancer Metastasis Res. 11:121-139.
16. Hockenbery, D. 1995. Defining apoptosis. Am. J. Pathol. 146:16-19.
17. Horiuchi, M., W. Hayashida, T. Kambe, T. Yamada, and V. J. Dzau. 1997. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272:19022-19026.
18. Ito, T., X. Deng, B. Carr, and W. S. May. 1997. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272:11671-11673.
19. Kaufmann, S. H., S. Desnoyers, Y. Ottaviano, N. E. Davidson, and G. G. Poirier. 1993. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976-3985.
20. Krebs, E. G., and J. A. Beavo. 1979. Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 88:923-939.
21. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
22. Kumar, N. 1981. Taxol-induced polymerization of purified tubulin. J. Biol. Chem. 256:10435-10441.
23. Lanotte, M., J. B. Riviere, S. Hermouet, G. Houge, O. K. Wintermyr, B. T. Gjertsen, and S. O. Doskeland. 1991. Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J. Cell Physiol. 146:73-80.
24. Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, G. G. Poirier, and W. C. Earnshaw. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
25. Martin, S. J., and D. R. Green. 1995. Protease activation during apoptosis. Death by a thousand cuts? Cell 82:349-352.
26. May, W. S., P. G. Tyler, T. Ito, D. K. Armstrong, K. A. Qatsha, and N. E. Davidson. 1994. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of Bcl2α in association with suppression of apoptosis. J. Biol. Chem. 269:26865-26870.
27. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449-1456.
28. Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik, N. A. Munday, S. M. Raju, M. E. Smulson, Y. Yamin, V. L. Yu, and D. K. Miller. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
29. Oltvai, Z. N., and S. J. Korsmeyer. 1994. Checkpoints of dueling dimers foil death wishes. Cell 79:189-192.
30. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619.
31. Park, J., I. Kim, Y. U. Oh, K.-W. Lee, H. Pyung-Lim, and E.-J. Choi. 1997. Activation of c-Jun N-terminal Kinase antagonizes an antiapoptotic action of Bcl2. J. Biol. Chem. 272:16725-16728.
32. Pietenpol, J. A., N. Papadopoulos, S. Markowitz, J. K. V. Willson, K. W. Kinzler, and B. Vogelstein. I994. Paradoxical inhibition of solid tumor cell growth by Bcl2. Cancer Res. 54:3714-3717.
33. Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Bioi. 124:1-6.
34. Sackett, D. I. 1995. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents. Biochemistry 34:7010-7019.
35. Sato, T., M. Hanada, S. Bodrag, S. Irie, N. Iwame, L. H. Boise, C. B. Thompson, S. Colemia, I. Fong, H.-G. Wary, and J. C. Reed. 1994. Interaction among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238-9242.
36. Scala, S., A. Budilon, Z. Zhan, Y. S. Cho-Chung, J. Jefferson, M. Tsokos, and S. E. Bates. 1995. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J. Clin. Invest. 96: 1026-1034.
37. Srivastava, R. K., A. R. Srivastava, and Y. S. Cho-Chung. 1998. Synergistic effects of 8-Cl-cAMP and retinoic acid on induction of apoptosis in Ewing's sarcoma CHP-100 cells. Clin. Cancer Res. 4:755-761.
38. Tang, C., M. C. Willingam, J. C. Reed, T. Miyashita, S. Ray, V. Ponnatpur, Y. Huang, M. E. Mahoney, G. Bullock, and K. Bhalla. 1994. High levels of p26Bc12 oncoprotein related taxol-induced apoptosis in human pre-B leukemia cells. Leukemia (Baltimore) 8:1960-1969.
39. Tewari, M., and V. M. Dixit. 1995. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus CrmA gene product. J. Biol. Chem. 270:3255-3260.
40. Tewari, M., L. T. Quan, K. O'Rourke, S. Desnoyers, S. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesen, and V. M. Dixit. 1995. Yama/CPP32β, a mammalian homolog of Ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801-809.
41. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science (Washington, D.C.) 267:1456-1460.
42. Tortora, G., G. D. Isernia, C. Sandomenico, R. Bianco, G. Pomatico, S. Pepe, A. R. Bianco, and F. Ciardiello. 1997. Synergistic inhibition of growth and induction of apoptosis by 8-cloro-cAMP and paclitaxel or cisplatin in human cancer cells. Cancer Res. 57:5107-5111.
43. Tortora, G., H. Yokozaki, S. Pepe, T. Clair, and Y. S. Cho-Chung. 1991. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 88:2011-2015.
44. cdc2 protein kinase in human fibroblasts. J. Biol. Chem. 28:19018-19022.
45. Vaux, D. L., G. Haecker, and A. Strasser. 1994. An evolutionary perspective on apoptosis. Cell 76:777-779.
46. Wang, L., M. Miura, L. Bergeron, H. Zhu, and L. Yuan. 1994. Ich-1, an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739-750.
47. L and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291.
48. Vintermyr, O. K., B. T. Gjersten, M. Lanotte, and S. O. Doskeland. 1993. Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp. Cell Res. 206:157-161.